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Abstract
Background: Intermittent fasting (IF) improves healthy lifespan in animals by a mechanism involving reduced
oxidative damage and increased resistance to stress. However, no studies have evaluated the impact of controlled
meal frequency on immune responses in human subjects.
Objective: A study was conducted to establish the effects of controlled diets with different meal frequencies, but
similar daily energy intakes, on cytokine production in healthy male and female subjects.
Design: In a crossover study design with an intervening washout period, healthy normal weight middle-age male
and female subjects (n = 15) were maintained for 2 months on controlled on-site one meal per day (OMD) or
three meals per day (TMD) isocaloric diets. Serum samples and peripheral blood mononuclear cells (PBMCs) culture
supernatants from subjects were analyzed for the presence of inflammatory markers using a multiplex assay.
Results: There were no significant differences in the inflammatory markers in the serum of subjects on the OMD
or TMD diets. There was an increase in the capacity of PBMCs to produce cytokines in subjects during the first
month on the OMD or TMD diets.
Lower levels of TNF-a, IL-17, MCP-1 and MIP-1b were produced by PBMCs from subjects on the OMD versus TMD
diet.
Conclusions: PBMCs of subjects on controlled diets exhibit hypersensitivities to cellular stimulation suggesting that
stress associated with altered eating behavior might affect cytokine production by immune cells upon stimulation.
Moreover, stimulated PBMCs derived from healthy individuals on a reduced meal frequency diet respond with a
reduced capability to produce cytokines.
Introduction
It has been hypothesized that due to limited availability
of food throughout the majority of human evolution, the
body was more adapted towards intermittent feeding
rather than to regular meal intervals as currently prac-
ticed in the developed world [1]. Regular access to high
calorie diets has contributed to an increase in obesity and
associated increases in morbidity and mortality [2]. Stu-
dies of obesity and its antithesis, caloric restriction (CR),
in humans and animals have provided insight into the
cellular and molecular mechanisms underlying normal
aging and chronic diseases including type 2 diabetes, car-
diovascular disease, cancers and neurodegenerative disor-
ders [3-5]. The multi-system pleiotropic effects of dietary
restriction also extend to the immune system. Many stu-
dies suggest that long-term CR improves several compo-
nents of immune function including responses of T cells
to mitogens, natural kill cell (NK) activity, cytotoxic T
lymphocyte (CTL) activity and the ability of mononuclear
cells to produce pro-inflammatory cytokines [6-8]. CR
attenuated the age-associated increase in ratio of memory
to naïve T cells in monkeys, and this was associated with
a reduction in the pro-inflammatory cytokines, TNF-a
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immune-enhancing effect of CR on NK cells and CTL
mediates, in part, the reduced incidence of tumors in
mice maintained on CR diets [10,11].
Data from controlled studies in rodents suggest that
intermittent fasting (IF) can protect against age-related
diseases and can extend lifespan, and that at least some
of the beneficial effects of IF may be independent of cal-
orie intake [1,4]. For example, alternate day fasting pro-
tected neurons in the brains of mice against dysfunction
and degeneration in models of Parkinson’sa n dA l z h e i -
mer’s diseases and stroke [12-14]. IF resulted in
improved glucose regulation and cardiovascular function
[15,16] and protected the heart against ischemia reperfu-
sion injury [17]. The latter study provided evidence that
the cardioprotective effect of IF is associated with an
attenuation of tissue inflammation. Increasing evidence
suggests that the signaling mechanisms that regulate
energy metabolism and immune function are tightly
coupled to each other [18,19]. For example, fasting can
significantly attenuate inflammation and the develop-
ment of autoimmune encephalomyelitis [20]. In addi-
tion, the orexigenic hormone ghrelin can act on various
immune cell subsets and inhibit pro-inflammatory cyto-
kine production [21]. Furthermore, genomic profiling
studies in rodents revealed that CR can reverse the
increased inflammation associated with aging [22] and
inhibit the release of proinflammatory mediators from
macrophages [23].
Recent findings from the Comprehensive Assessment
of Long-Term Effects of Reducing Intake of Energy
(CALERIE) study suggest that CR has effects on energy
metabolism and disease risk in humans that are similar
to those seen in rodents [24]. In humans, long-term CR
was reported to be highly effective in reducing the risk
for atherosclerosis and associated pro-inflammatory
markers [25], and moderate CR improved cell-mediated
immunity [26]. In contrast to the increasing literature
describing effects of CR on the immune system, there
have been no reports of studies of how reduced meal
frequency/IF affects immune function. It was recently
reported that an alternate day calorie restriction IF diet-
ary regimen resulted in a marked improvement in the
symptoms of asthma patients, and an associated reduc-
tion in serum markers of oxidative stress and inflamma-
tion [27]. However, the IF diet included a large
reduction in calorie intake such that the relative contri-
butions of CR and fasting to the outcomes is unknown.
We have previously reported on a human meal fre-
quency study in which the daily calories were held con-
stant between two diets that differed only in meal
frequency (3 smaller meals versus one large meal). In
this study, a large number of physiological variables
were measured, including heart rate, body temperature
and blood chemicals and many of these were unaffected
by altering meal frequency [28]. However, when on 1
meal per day, subjects did exhibit a significant reduction
of fat mass and significant increases in levels of total,
low-density lipoprotein, and high density lipoprotein
cholesterol. Moreover, in this same study, Carlson and
c o w o r k e r s[ 2 9 ]d e m o n s t r a t e dt h a tt h em o r n i n gg l u c o s e
tolerance was found to be impaired in subjects consum-
ing 1 meal per day compared with 3 meals per day.
Fasting (morning) plasma glucose levels were also signif-
icantly elevated in subjects when they were consuming 1
meal per day (OMD) compared with 3 meals per day
(TMD). This OMD diet effect on glucose tolerance was
rapidly reversed upon return to the TMD diet, indicat-
ing that the diet had no long-lasting effect on glucose
metabolism. Interestingly, there were no significant
effects of meal frequency on plasma levels of ghrelin,
adiponectin, resistin or BDNF.
In a follow-up to these studies, we have here exam-
ined the impact of different meal frequencies (without a
difference in calorie intake) on plasma inflammatory
markers (CRP, sgp130, visfatin) and activation-induced
PBMC cytokine expression in normal weight human
male and female subjects. Our data suggest that a
change in diet causes a transient increase in TCR- and
TLR4-mediated pro-inflammatory cytokine production
by peripheral blood mononuclear cells (PBMCs), and
that the magnitude of these alterations is less when sub-
jects consume OMD vs. TMD.
Subjects and Methods
Subjects, Study Design and Diets
Details of the subject population, selection criteria and
study design have been reported [28]. Briefly, subjects
were healthy 40-50 year-old males and females with a
body mass index (BMI) between 18 and 25 kg/m
2 with
a usual eating pattern of TMD. The experimental proto-
col was approved by the Johns Hopkins University Com-
mittee on Human Research and the MedStar Research
Institute Institutional Review Board, and all subjects
gave their informed consent. As this is the first study of
its kind, there is no historical data for comparison in
design and to determine wash out periods. This study
was designed based on animal studies in which we
found that many physiological variables (heart rate,
blood pressure, insulin levels) returned to baseline levels
within 2-4 weeks of wash-out [1,12-14]. Thus, the sub-
jects in this study were divided into two controlled diet
g r o u p s ,aT M Dd i e ta n da nO M Dd i e t ,i naw a s h o u t
and crossover design - 2 months on diets, 2 months off
diets, crossover 2 months on diet - with the study last-
ing 6 months. During both 2-month controlled diet per-
iods, each subject consumed dinner at the Human Study
Facility under the supervision of a registered dietitian.
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allowed to be consumed during the study. Subjects were
allowed unlimited amounts of caloric-free liquids and
foods. Prior to initiation of the experimental diets, the
energy requirements for weight maintenance were calcu-
lated for each subject using the Harris- Benedict for-
mula, which estimates basal energy expenditure, and
multiplied by an activity factor of 1.3-1.5. This formula
has proven successful in estimating weight-maintenance
energy requirements at our facility. For the entire study
the average daily calorie intakes were 2364 kcal in the 1
meal/d diet and 2429 kcal in the 3 meals/d diet. More
details on the diet composition and methods used to
evaluate compliance with the diets are reported else-
where [28,29].
As for the population of subjects examined in this
study, the number of subjects (n) examined for each
stage of the study are as follows: Pre-treatment/Baseline
(n = 15), 1 meal/1 month (n = 8), 1 meal/2 month (n =
12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3
meal/2 month (n = 12). Complete data were analyzed
and are presented for 15 subjects. In the TMD diet arm,
1 subject withdrew because of food dislikes. During the
OMD, 5 subjects withdrew because of scheduling con-
flicts and health problems unrelated to the study. Only
1 of the 5 subjects withdrew specifically because of an
unwillingness to consume the 1 meal/d diet.
Separation and stimulation of peripheral blood
mononuclear cells (PBMCs)
The PBMCs were separated from fresh heparinized
blood of healthy adult donors using Ficoll density gradi-
ent centrifugation, followed by extensive washing in
phosphate-buffered saline (PBS). The erythrocytes were
removed by hypotonic shock (ACK lysis buffer, Quality
Biological, Bethesda, MD). The PBMCs were subse-
quently cultured in serum-free medium (AIM-V) and
stimulated with either plate-bound anti-CD3 mAb (200
ng/ml) or E. coli LPS (10 μg/ml) for 24 hours as
described previously [21].
Cytokine analysis
Serum and cell culture supernatants were analyzed for
cytokines using Bio-Plex Cytokine 17-Plex Panel accord-
ing to manufacturer’s instructions (Biorad Laboratories,
Hercules, CA).
Real Time PCR analysis
The PBMCs were lysed in RNA lysis buffer and total
RNA was extracted from control and stimulated cells
using a QIAshredder kit (QIAgen). RNA (500 μg) and
oligo-dT primers were used to synthesize single-
stranded cDNA. PCR was then performed using SYBR
green Master Mix (Applied Biosystems, Foster City,
California, USA), 1 μl cDNA, and exon spanning gene-
specific primers. Thermal cycling was performed using
the Applied Biosystems GeneAmp 7700 Sequence
Detector.
Statistical Analysis
Data are presented as the mean and SEM. An analysis of
variance appropriate for a 2 period crossover study with
repeated measures within period was used to evaluate
meal frequency effects on outcome variables. The Stu-
dent-Newman-Keuls test was employed to test the sig-
nificance of difference observed in the two study groups.
Results
Serum Markers of Inflammation
Measurement of C-reactive protein (CRP), ICAM-1,
VCAM-1 and soluble gp130 proteins in the peripheral
circulation reflect the basal inflammatory state [30].
CRP levels were elevated in subjects when they were on
the OMD diet compared to the TMD diet (Figure 1A).
There were no significant effects of diet on serum levels
of sgp130 (Figure 1B), ICAM-1 (Figure 2A) or VCAM-1
(data not shown). In addition, diet demonstrated no sig-
nificant effects on levels of circulating visfatin (nicotina-
mide phosphoribosyltransferase; Pre-B cell colony
enhancing factor) (Figure 2B), a recently identified adi-
pocytokine that has insulin-mimetic effects [31] and
pro-inflammatory properties [32,33].
Cytokine Secretion from Peripheral Blood Mononuclear
Cells
In the absence of antigenic challenge, immune cells pro-
duce negligible or low levels of pro-inflammatory cyto-
kines. In an effort to understand the impact of meal
frequency on lymphocyte responsiveness to an immune
challenge, we isolated PBMC from subjects on OMD and
TMD diets and challenged them ex-vivo. Due to the lim-
itations on volume of blood collections from subjects and
the availability of buffy coats in the study, isolation of
specific immune cell subsets was not feasible. In an effort
to understand the cytokine secretory responses of
immune cell subsets, LPS was utilized to stimulate B cells
and monocytes via toll-like receptor 4 (TLR4), while the
T cells in the mixed PBMC populations were specifically
activated by TCR ligation. TNF-a production induced by
LPS and anti-CD3 mAb treatment was significantly
greater during the first month on either the OMD or
TMD controlled diet periods compared to the pretreat-
ment and washout time points (Figure 3A). The increase
in TNF-a levels at the one month time point was fol-
lowed by a return towards baseline during the subse-
quent one month of the both the TMD and OMD diet
periods. However, the magnitude of the elevation of
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Page 3 of 13Figure 1 Serum CRP and soluble gp130 levels from OMD and TMD fed subjects at various time points during the study. (A.) Serum
CRP and (B.) soluble gp130 (sGP130) concentrations were examined at the indicated time points. The data are expressed in pg/ml (+/- SEM).
OMD, one meal per day controlled diet; TMD, three meals per day controlled diet. The numbers of subjects (n) examined for each stage of the
study are as follows: Pre-treatment/Baseline (n = 15), 1 meal/1 month (n = 8), 1 meal/2 month (n = 12), Off-diet (n = 12), 3 meals/1 month (n =
12) and 3 meal/2 month (n = 12).
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Page 4 of 13Figure 2 Serum CRP and soluble gp130 levels from OMD and TMD fed subjects at various time points during the study. (A.) Serum
intercellular adhesion molecule-1 (ICAM-1) and (B.) visfatin concentrations were examined at the indicated time points. The data are expressed
in pg/ml (+/- SEM). The numbers of subjects (n) examined for each stage of the study are as follows: Pre-treatment/Baseline (n = 15), 1 meal/1
month (n = 8), 1 meal/2 month (n = 12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3 meal/2 month (n = 12).
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Page 5 of 13Figure 3 Stimulated PBMCs derived from subjects on OMD and TMD diets were examined for TNF-a and IFN-g expression.P e r i p h e r a l
blood mononuclear cells derived from OMD and TMD diets were stimulated ex-vivo with anti-CD3 mAb or LPS. In both the study groups, there
was a statistically significant (p < 0.05) increase in TNF-a and levels in culture supernatants at one month after initiation of dietary regimens. (A)
LPS-induced TNF-a release at 1 month time point was significantly lower in OMD fed subjects compared to the TMD group. No significant
differences could be detected at other time points and in response to anti-CD3 mAb stimulation. (B) T cell activation by TCR-dependent
mechanisms (anti-CD3 mAb) results in a lower IFN-g release at one month time point in subjects fed OMD versus those fed TMD. The data are
expressed in pg/ml (+/- SEM). The numbers of subjects (n) examined for each stage of the study are as follows: Pre-treatment/Baseline (n = 15),
1 meal/1 month (n = 8), 1 meal/2 month (n = 12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3 meal/2 month (n = 12).
Dixit et al. Journal of Inflammation 2011, 8:6
http://www.journal-inflammation.com/content/8/1/6
Page 6 of 13TNF-a level at one month was greater when the subjects
ate TMD compared to OMD (Figure 3A).
Similar to TNF-a, there was a transient increase in the
amount of Th-1 cytokine, IFN-g secreted in response to
anti-CD3 mAb stimulation in PBMC from subjects at 1
month after initiation of either OMD or TMD diets
(Figure 3B). The magnitude of enhancement of IFN-g
production was significantly greater in subjects on TMD
compared to OMD. Both basal and anti-CD3 mAb-sti-
mulated production of IL-6 were elevated at the 1
month on-diet time point compared to the pretreat-
ment, off-diet, and 2 month on-diet time points (Table
1). Anti-CD3 mAb-stimulated production of IL-1b by
PBMCs was also significantly greater at the 1 month on-
diet time point in both the OMD and TMD groups
compared to other time points (Table 1). Compared to
the pretreatment time point, the level of IL-2 produced
in response to stimulation with anti-CD3 mAb was ele-
vated at all of the other time points during the 6 month
study period (Table 1). Levels of GM-CSF and G-CSF
produced by PBMCs in response to stimulation with
either anti-CD3 mAb or LPS treatment were signifi-
cantly greater at the 1 month on-diet time points for
both the OMD and TMD diet groups, with the levels
being greatest when subjects were consuming TMD
(Table 1). Levels of IL-10 produced in response to sti-
mulation with anti-CD3 mAb were greatest at the 1
month on-diet time points for both the OMD and TMD
groups (Table 1).
A subset of IL-17 producing T (Th17) cells distinct
from Th-1 or Th-2 cells has been described and shown
to play a critical role in the induction of autoimmune dis-
eases [34,35]. Interestingly, we observed a significantly
higher production of IL-17 from anti-CD3 stimulated T
cells in the subjects when on the TMD diet compared to
the OMD diet (Figure 4A). The mRNA expression of IL-
17 receptor from pooled cDNA samples of subjects in
OMD and TMD did not show any significant changes.
IL-23 has recently been reported to play a role in the
development of IL-17-producing T helper cells [36]. In
an effort to understand the possible mechanism responsi-
ble for increased IL-17 release in subjects on the TMD,
we measured IL-23 mRNA levels by real-time PCR analy-
sis in the anti-CD3 mAb activated PBMCs. We observed
a 4- to 5-fold higher IL-23 mRNA expression in subjects
when they were on the TMD diet compared to OMD
diet (Figure 4B); consistent with the possibility that IL-23
regulates IL-17 expression.
The effects of diet on Th-1 and Th17 cytokine expres-
sion were not associated with any significant effect on
the Th-2 cytokines IL-4 and IL-5 (Figure 5A) or IL-10
(Table 1). There were no statistically significant effects
of diet on ant-CD3 mAb- or LPS-induced production of
IL-13, although there was a clear trend towards
increased IL-13 responses at the one month time point
for both the TMD and OMD diets (Figure 5B). The pro-
duction of IL-1, IL-6, G-CSF and GM-CSF by activated
PBMCs were elevated at the one month OMD and one
month TMD time points, compared to the other time
points (Table 1), suggesting that a change from normal
to controlled diets affects these cytokine regulatory
pathways.
Table 1 Anti-CD3 mAb- and LPS-induced cytokine expression by PBMCs derived from OMD and TMD fed subjects at
various time periods during the trial
Cytokines Pretreatment 1 meal, 1 month 1 meal, 2 months Off diet 3 meals, 1 month 3 meals, 2 months
Subject Number 15 8 12 12 12 12
IL-6 (pg/ml)
Unstimulated
520.5
± 420.3
1290.2
± 52.9
275.8
± 52.9
871.6
± 420.8
2653.8
± 912.5
459.2
± 154.3
IL-6 (pg/ml)
Anti-CD3 mAb
1089.2
± 195.6
32794.2
± 17902.1
4163.2
± 647.5
19669.1
± 13184.2
61393
± 34081
4291.8
± 736.4
IL-1b (pg/ml)
Anti-CD3 mAb
229.4
± 47.2
3778.6
± 2181.4
243.4
± 61.5
1429.3
± 897.6
4234.6
± 1526.9
245.3
± 59.8
IL-2 (pg/ml)
Anti-CD3 mAb
28.3
± 5.2
121.5
± 78.3
85.4
± 33.2
174.6
± 146.3
146.5
± 63.8
288.4
± 139.6
GM-CSF (pg/ml)
Anti-CD3 mAb
45.2
± 4.2
279.8
± 12.7
44.6
± 7.8
347.3
± 263.5
679.1
± 259.6
109.3
± 55.96
GM-CSF (pg/ml)
LPS
63.2
± 11.5
169.3
± 96.8
74.6
± 12.3
82.6
± 22.3
934.6
± 50.7
274.3
± 169.5
G-CSF (pg/ml)
Anti-CD3 mAb
98.4
± 62.3
264.5
± 146.3
55.6
± 12.1
103.6
± 62.2
405.9
± 125.4
54.2
± 16.2
G-CSF (pg/ml)
LPS
1075.4
± 221.1
7912
± 5880.1
2195.3
± 374.6
2669.4
± 1008.6
10608.2
± 4633.8
4466.1
± 2213.5
IL-10 (pg/ml)
Anti-CD3 mAb
270.5
± 63.1
3960.1
± 3103
381.7
± 81.6
2055.4
± 1699.5
4404.5
± 1398.9
524.5
± 212.6
a Mean (pg/ml ± SEM) concentration of various cytokines measured in culture supernatants in response to LPS- and TCR-mediated activation stimuli.
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Page 7 of 13Figure 4 Stimulated PBMCs derived from subjects on OMD and TMD diets were examined for IL-17 production and for mRNA
expression of IL-17R and IL-23. PBMCs isolated from subjects at the indicated time points were stimulated with anti-CD3 mAb antibody. (A.)
The IL-17 secretion at 1 month time point was significantly lower in OMD fed subjects compared to TMD (p < 0.05). The data are expressed in
pg/ml (+/- SEM). (B.) Equal amounts of cDNA from individual donors were analyzed for IL-17R and IL-23 mRNA levels using real-time RT-PCR.
Each sample was run in duplicate and the threshold value (Ct) was normalized to GAPDH and is expressed as average fold change. The
numbers of subjects (n) examined for each stage of the study are as follows: Pre-treatment/Baseline (n = 15), 1 meal/1 month (n = 8), 1 meal/2
month (n = 12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3 meal/2 month (n = 12).
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Page 8 of 13Figure 5 Stimulated PBMCs derived from subjects on OMD and TMD diets were examined for IL-4, IL-5 and IL-13 expression. (A.) The
production of classical T helper-2 cytokines, IL-4 and IL-5 from anti-CD3 mAb stimulated PBMCs demonstrated no significant difference between
OMD and TMD diet groups. (B.) There were no significant effects of diet on the capacity of PBMCs to release IL-13. The data are expressed in
pg/ml (+/- SEM). The numbers of subjects (n) examined for each stage of the study are as follows: Pre-treatment/Baseline (n = 15), 1 meal/1
month (n = 8), 1 meal/2 month (n = 12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3 meal/2 month (n = 12).
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Page 9 of 13Figure 6 Stimulated PBMCs derived from subjects on OMD and TMD diets were examined for MCP-1 and MIP-1b expression.
Production of MCP-1 and MIP-1b could be detected in the culture supernatant from un-stimulated PBMCs. The LPS-induced MCP-1 and MIP-1b
release from PBMCs was significantly lower at one month time point in subjects fed OMD versus TMD (p < 0.05). The data are expressed in pg/
ml (+/-SEM). The numbers of subjects (n) examined for each stage of the study are as follows: Pre-treatment/Baseline (n = 15), 1 meal/1 month
(n = 8), 1 meal/2 month (n = 12), Off-diet (n = 12), 3 meals/1 month (n = 12) and 3 meal/2 month (n = 12).
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matory chemokines; MCP-1 and MIP-1b by PBMCs
treated with LPS and anti-CD3 mAb, and observed sig-
nificantly lower production of these chemokines in sub-
jects when on OMD and TMD diets compared to
pretreatment and off diet time points (Figure 6A, B).
The magnitude of the elevation of the latter proinflam-
matory cytokines was greater when subjects were on the
TMD diet compared to the OMD diet.
Discussion
Although there is ample anecdotal evidence of health
benefits of fasting in the healthy adults, only recently
have such dietary interventions been rigorously studied
in laboratory animals and human subjects. Emerging
evidence suggests that mice and rats maintained on
repeated cycles of 24 hours with no food followed by 24
hours with free access to food (IF) lived up to 30%
longer [37,38] compared to ad libitum fed controls. In
addition, the IF animals displayed improved insulin sen-
sitivity, reduced cancers and increased resistance of neu-
rons and cardiac cells to oxidative and metabolic stress
[17,39]. However, the effects of meal frequency and
intermittent fasting on immune function in humans are
unknown. Given the highly robust beneficial effects of
IF in experimental models, we designed the present
study in humans to test the hypothesis that a change
from a usual TMD diet to an OMD weight maintenance
diet would alter proinflammatory cytokine expression in
circulating lymphocytes. Analysis of serum levels of the
proinflammatory markers, CRP, ICAM-1 and soluble
gp130 revealed no significant differences between the
OMD and TMD diet groups. We also studied serum
visfatin, a novel adipocytokine, which is synthesized
mainly by visceral adipocytes and serves as an insulin
mimetic and proinflammatory cytokine [31-33]. Similar
to other proinflammmatory markers, we observed that
OMD and TMD diets have no impact on serum visfatin
levels in these subjects. Thus, meal frequency did not
significantly affect levels of circulating pro-inflammatory
markers, suggesting that a change in meal frequency
does not alter the basal inflammatory state.
Because the subjects in our study were healthy and of
normal weight, and so would not be expected to display
elevated pro-inflammatory markers, we studied the
impact of fasting on regulation of T-helper cytokines
and chemokines from PBMCs isolated from the subjects
at designated time points throughout the study. The iso-
lated PBMCs were activated ex-vivo with LPS and TCR
ligation. Compared to the baseline pretreatment values,
we observed a large unexpected increase in cytokine
secretion from stimulated cells one month after initia-
tion of either the OMD or TMD diets. Although the
precise mechanism responsible for this elevated cytokine
release is unknown, it is quite feasible that departure
from pre-study regular eating patterns and adherence to
OMD and TMD controlled diets in both study groups
made the PBMCs hyper-responsive to stimulation. As
the study progressed into the second month of the con-
trolled TMD and OMD diet periods, the stimulated
cytokine levels in the subjects returned closer to the
baseline suggesting a habituation and adaptation to the
dietary intervention. A stress-based mechanism for the
enhanced responsiveness of PBMC when subjects were
on the TMD and OMD controlled diet would be consis-
tent with previous studies have provided evidence that
mild stress can enhance PBMC activation. For example,
P B M C si s o l a t e df r o ms u b j e c t sf o l l o w i n ge x p o s u r et o
psychosocial stress [40] or 5 min of vigorous exercise
[41] exhibited increased activation of NF-B, a tran-
scription factor know to induce the production of var-
ious cytokines. In addition, chemotaxis and expression
of cell adhesion molecules were increased in PBMCs
isolated from subjects immediately after acute psycholo-
gical stress [42].
This meal frequency study was the first human study
in which daily calories were held constant between two
diets that differed only in meal frequency (3 smaller
meals versus one large meal) [28]. A large number of
physiological variables were measured, including heart
rate, body temperature and blood chemicals and many
of these were unaffected by altering meal frequency.
However, when on 1 meal per day, subjects did exhibit
a significant reduction of fat mass and significant
increases in levels of total, low-density lipoprotein, and
high density lipoprotein cholesterol [28]. In addition, the
morning glucose tolerance was found to be impaired
when subjects were consuming 1 meal per day com-
pared with 3 meals per day [29]. Fasting (morning)
plasma glucose levels were also significantly elevated in
subjects when they were consuming 1 meal per day
compared with 3 meals per day and this 1-meal-per-day
diet effect on glucose tolerance was rapidly reversed
upon return to the 3-meals-per-day diet, indicating that
the diet had no long-lasting effect on glucose metabo-
lism. Besides these effects on glucose metabolism, there
were no significant effects on the expression of a num-
ber of metabolic variables including plasma levels of
ghrelin, adiponectin, resistin or BDNF. In the current
study, we have further examined these subjects for
alterations in inflammatory and immune parameters
w i t hc h a n g e si nd i e ta n dn o t e dt h a tm e a lf r e q u e n c y
changes do cause transient increases in TCR- and TLR4
(LPS)-mediated expression of several cytokines and that
the magnitude of these alterations is less when subjects
consume OMD versus TMD. Interesting patterns of
expression were revealed where there appears to be
more of a stress response at the initiation of the diets at
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expression changes were noted in the 1 month time per-
iod of the TMD subjects versus the same subjects given
OMD supporting our conclusions that reduced meal fre-
quency can have an impact on PBMC-derived cytokine
expression between OMD and TMD subjects. Despite
the observed changes in metabolic parameters reported
in this study [28,29], we failed to note any significant
correlations or associations between the observed cyto-
kine changes in expression with diet and BMI or circu-
lating levels of glucose, insulin, leptin, ghrelin,
adiponectin, resistin or BDNF.
In the first month after the initiation of the diets, we
observed a robust increase in IFN- g and TNF-a release
from PBMCs in subjects fed TMD that was significantly
g r e a t e rt h a nw h e nt h es u b j e c t sw e r eo nt h eO M Dd i e t .
In a smaller study, the immune cells derived from fed
healthy subjects and stimulated ex vivo by TCR ligation
produced significantly higher levels of IFN- g with lower
IL-4 levels compared to overnight fasted individuals [43]
suggesting that fasting promotes Th2 responses. In our
study no significant differences were observed in Th2
cytokines from OMD and TMD groups; however similar
to the previous study [43], we observed lower levels of
Th1 cytokines in subjects when they were on the OMD
diet. We have also recently reported that alternate day
calorie restriction in overweight adults with asthma
results in marked decline in circulating TNF-a levels
with improvement in pulmonary functions and measures
of quality of life [27]. Recent studies suggest that in
addition to Th1 and Th2 there is a subset of IL-17 pro-
ducing T helper cells (Th17) that are involved in various
autoimmune inflammatory disorders [36,44]. Compared
to the TMD diet, we observed significantly reduced IL-
17 secretion from stimulated T cells derived from sub-
jects during the OMD diet. It has been suggested that
IL-23 is a key regulator of I L - 1 7p r o d u c t i o ni nTc e l l s
[35,36]. We observed that PBMCs from subjects on
TMD for 2 months expressed 6-fold higher levels of IL-
23 mRNA compared to the baseline level, with no dif-
ference in IL-17 receptor expression. Recent studies sug-
gest that fasting induced down-regulation of leptin
protects against autoimmune encephalomyelitis [45,46].
Our data suggest for the first time that fasting can also
down regulate the IL-17 pathway in human T cells and
hence could modify autoimmune processes. Interest-
ingly, compared to the TMD diet group, we also
observed a significant reduction in MCP-1 and MIP-1b
production from stimulated PBMCs derived from OMD
fed subjects suggesting a tight coupling of metabolic and
immune systems.
In conclusion, our study demonstrates that upon spe-
cific challenges ex vivo, leukocytes cells derived from
subjects on an OMD diet respond with lower pro-
inflammatory cytokine production. The immune com-
partment appears to be exquisitely sensitive to the beha-
vioral and metabolic cues, and the application of
intermittent fasting as an approach for modifying
immune function to improve health warrants further
study.
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